These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2912719)

  • 41. Association of drug levels & pharmacokinetics of carbamazepine with seizure control.
    Vasudev A; Tripathi KD; Puri V
    Indian J Med Res; 2000 Dec; 112():218-23. PubMed ID: 11247200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects.
    Flesch G; Tudor D; Souppart C; D'Souza J; Hossain M
    Int J Clin Pharmacol Ther; 2002 Nov; 40(11):524-32. PubMed ID: 12698990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled, multidose, pharmacokinetic evaluation of two extended-release carbamazepine formulations (Carbatrol and Tegretol-XR).
    Stevens RE; Limsakun T; Evans G; Mason DH
    J Pharm Sci; 1998 Dec; 87(12):1531-4. PubMed ID: 10189261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical monitoring during carbamazepine slow-release, once-daily monotherapy.
    Stefan H; Schäfer H; Kuhnen C; Schneider S
    Epilepsia; 1988; 29(5):571-7. PubMed ID: 3137020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoinduction of carbamazepine metabolism in children examined by a stable isotope technique.
    Bertilsson L; Höjer B; Tybring G; Osterloh J; Rane A
    Clin Pharmacol Ther; 1980 Jan; 27(1):83-8. PubMed ID: 7351120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine: individual variation in relation to seizure frequency and type.
    Schmidt D; Haenel F
    Neurology; 1984 Sep; 34(9):1252-5. PubMed ID: 6540414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous carbamazepine for the treatment of epilepsy.
    Brigo F; Leo A; Russo E; Striano P; Belcastro V
    Expert Opin Pharmacother; 2018 May; 19(7):743-747. PubMed ID: 29648925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of clobazam on steady state plasma concentrations of carbamazepine and its metabolites.
    Muñoz JJ; De Salamanca RE; Diaz-Obregón C; Timoneda FL
    Br J Clin Pharmacol; 1990 Jun; 29(6):763-5. PubMed ID: 2378792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Free and total serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in infancy and childhood.
    Riva R; Contin M; Albani F; Perucca E; Lamontanara G; Baruzzi A
    Epilepsia; 1985; 26(4):320-2. PubMed ID: 4006891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects.
    Monaco F; Riccio A; Benna P; Covacich A; Durelli L; Fantini M; Furlan PM; Gilli M; Mutani R; Troni W; Gerna M; Morselli PL
    Neurology; 1976 Oct; 26(10):936-73. PubMed ID: 986584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of carbamazepine on heart conduction in young patients: a serial study using ambulatory ECG].
    Matteoli S; Trappolini M; Curione M; Fanari F; Borgia MC; Puletti M
    G Ital Cardiol; 1994 Apr; 24(4):391-7. PubMed ID: 8056214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Open randomized comparative trial of sodium valproate and carbamazepine in adult onset epilepsy].
    Czapiński P; Terczyński A
    Neurol Neurochir Pol; 1996; 30(3):419-26. PubMed ID: 8965976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.
    Markoula S; Chatzistefanidis D; Gatzonis S; Siatouni A; Siarava E; Verentzioti A; Kyritsis AP; Patsalos PN
    Seizure; 2017 May; 48():1-6. PubMed ID: 28363098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New statistical method for analyzing time to first seizure: example using data comparing carbamazepine and valproate monotherapy.
    Cowling BJ; Shaw JE; Hutton JL; Marson AG
    Epilepsia; 2007 Jun; 48(6):1173-8. PubMed ID: 17553118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative pharmacokinetic study of chewable and conventional carbamazepine in children.
    Cornaggia C; Gianetti S; Battino D; Granata T; Romeo A; Viani F; Limido G
    Epilepsia; 1993; 34(1):158-60. PubMed ID: 8422850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication.
    Kong ST; Lim SH; Chan E; Ho PC
    J Clin Pharmacol; 2014 Feb; 54(2):225-33. PubMed ID: 23996245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Approvable generic carbamazepine formulations may not be bioequivalent in target patient populations.
    Tothfalusi L; Endrenyi L
    Int J Clin Pharmacol Ther; 2013 Jun; 51(6):525-8. PubMed ID: 23611573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of two generically equivalent carbamazepine preparations.
    Kauko K; Tammisto P
    Ann Clin Res; 1974; 6(0):suppl 11:21-5. PubMed ID: 4851115
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of viloxazine on serum carbamazepine levels in epileptic patients.
    Pisani F; Narbone MC; Fazio A; Crisafulli P; Primerano G; D'Agostino AA; Oteri G; Di Perri R
    Epilepsia; 1984 Aug; 25(4):482-5. PubMed ID: 6745218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.